Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

Bibliographic Details
Main Authors: Ni Zhao, Ye Yi, Wen Cao, Xiao Fu, Nan Mei, Chunli Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1069999/full
_version_ 1811187453181034496
author Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li
author_facet Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li
author_sort Ni Zhao
collection DOAJ
first_indexed 2024-04-11T14:03:44Z
format Article
id doaj.art-77183d308c52458cb5c03040a8ab581e
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T14:03:44Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-77183d308c52458cb5c03040a8ab581e2022-12-22T04:19:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10699991069999Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapyNi Zhao0Ye Yi1Wen Cao2Xiao Fu3Nan Mei4Chunli Li5Department of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, ChinaDepartment of Respiratory Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, ChinaDepartment of Hematology. The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xi’’an Jiaotong University, Xi’an, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2022.1069999/fullbiomarkerscytokinesimmunotherapylung cancerimmune related adverse events
spellingShingle Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li
Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
Frontiers in Oncology
biomarkers
cytokines
immunotherapy
lung cancer
immune related adverse events
title Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_full Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_fullStr Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_full_unstemmed Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_short Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_sort corrigendum serum cytokine levels for predicting immune related adverse events and the clinical response in lung cancer treated with immunotherapy
topic biomarkers
cytokines
immunotherapy
lung cancer
immune related adverse events
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1069999/full
work_keys_str_mv AT nizhao corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT yeyi corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT wencao corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT xiaofu corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT nanmei corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT chunlili corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy